Goldman Sachs’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.27M | Buy |
|
|||||
|
2025
Q2 | $715K | Sell |
|
|||||
|
2025
Q1 | $3.9M | Buy |
|
|||||
|
2024
Q4 | $4.07M | Buy |
|
|||||
|
2024
Q3 | $1.19M | Sell |
|
|||||
|
2024
Q2 | $394K | Sell |
|
|||||
|
2024
Q1 | $1.45M | Buy |
|
|||||
|
2023
Q4 | $74.5K | Sell |
|
|||||
|
2023
Q3 | $84K | Hold |
|
|||||
|
2023
Q2 | $117K | Sell |
|
|||||
|
2023
Q1 | $104K | Buy |
|
|||||
|
2022
Q4 | $94.9K | Sell |
|
|||||
|
2022
Q3 | $150K | Buy |
|
|||||
|
2022
Q2 | $87K | Sell |
|
|||||
|
2022
Q1 | $145K | Buy |
|
|||||
|
2021
Q4 | $89K | Buy |
|
|||||
|
2021
Q3 | $89K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $179K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $34K | Sell |
|
|||||
|
2017
Q1 | $195K | Sell |
|
|||||
|
2016
Q4 | $201K | Sell |
|
|||||
|
2016
Q3 | $327K | Sell |
|
|||||
|
2016
Q2 | $417K | Sell |
|
|||||
|
2016
Q1 | $274K | Sell |
|
|||||
|
2015
Q4 | $347K | Sell |
|
|||||
|
2015
Q3 | $558K | Buy |
|
|||||
|
2015
Q2 | $325K | Buy |
|